RNA steady-state defects in myotonic dystrophy are linked to nuclear exclusion of SHARP

EMBO Rep. 2011 Jul 1;12(7):735-42. doi: 10.1038/embor.2011.86.

Abstract

We describe a new mechanism by which CTG tract expansion affects myotonic dystrophy (DM1). Changes to the levels of a panel of RNAs involved in muscle development and function that are downregulated in DM1 are due to aberrant localization of the transcription factor SHARP (SMART/HDAC1-associated repressor protein). Mislocalization of SHARP in DM1 is consistent with increased CRM1-mediated export of SHARP to the cytoplasm. A direct link between CTG repeat expression and SHARP mislocalization is demonstrated as expression of expanded CTG repeats in normal cells recapitulates cytoplasmic SHARP localization. These results demonstrate a role for the inactivation of SHARP transcription in DM1 biology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / pharmacology
  • Cell Nucleus / metabolism*
  • Cytoplasm / metabolism
  • DNA-Binding Proteins
  • Fatty Acids, Unsaturated / pharmacology
  • Gene Expression Regulation
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism*
  • Humans
  • Myoblasts / metabolism
  • Myotonic Dystrophy / genetics
  • Myotonic Dystrophy / physiopathology*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Protein Transport / drug effects
  • RNA / metabolism*
  • RNA Splicing / genetics
  • RNA-Binding Proteins / metabolism
  • Trinucleotide Repeat Expansion / genetics

Substances

  • Antibiotics, Antineoplastic
  • DNA-Binding Proteins
  • Fatty Acids, Unsaturated
  • Homeodomain Proteins
  • MBNL3 protein, human
  • Nuclear Proteins
  • RNA-Binding Proteins
  • SIX5 protein, human
  • SPEN protein, human
  • RNA
  • leptomycin B